Susmed (TSE:4263) EV-to-FCF: (As of Jul. 06, 2026)


TSE:4263 Susmed Inc TSE:4263
69 GF Score
Price 円818.00
GF Value 円974.33
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Susmed EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Susmed's Enterprise Value is 円10,222.8 Mil. Susmed's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.0 Mil. Therefore, Susmed's EV-to-FCF for today is .

The historical rank and industry rank for Susmed's EV-to-FCF or its related term are showing as below:

TSE:4263' s EV-to-FCF Range Over the Past 10 Years
Min: -22.59   Med: 0   Max: 0
Current: -22.59

TSE:4263's EV-to-FCF is ranked worse than
100% of 404 companies
in the Healthcare Providers & Services industry
Industry Median: 17.75 vs TSE:4263: -22.59

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-06), Susmed's stock price is 円818.00. Susmed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円-28.830. Therefore, Susmed's PE Ratio (TTM) for today is At Loss.


Susmed  (TSE:4263) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Susmed's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=818.00/-28.830
=At Loss

Susmed's share price for today is 円818.00.
Susmed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-28.830.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Susmed EV-to-FCF Related Terms


Susmed EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Susmed's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Susmed EV-to-FCF Chart

Susmed Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EV-to-FCF
Get a 7-Day Free Trial 0.00 -55.12 298.62 -21.70 -12.99

Susmed Quarterly Data
Jun20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -12.99 0.00 0.00

TSE:4263 vs VEEV, BTSG, TEM: EV-to-FCF Comparison

For the Health Information Services subindustry, Susmed's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Susmed EV-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Susmed's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Susmed's EV-to-FCF falls into.


TSE:4263
69GF Score
Susmed Inc TSE:4263
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Susmed EV-to-FCF Calculation

Susmed's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=10222.822/0
=

Susmed's current Enterprise Value is 円10,222.8 Mil.
Susmed's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Susmed (TSE:4263) Overvalued in 2026?

Based on GuruFocus' analysis, Susmed stock appears to be undervalued. The current stock price of 円818.00 is trading 16% below its estimated GF Value™ of 円974.33. GuruFocus considers Susmed to be Modestly Undervalued.

Key valuation signals for TSE:4263:

  • EV-to-FCF:
  • GF Value™: 円974.33 vs. price of 円818.00 (16% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the TSE:4263 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Susmed Business Description

Address 3-7-2 Nihonbashi Honcho, 10th Floor, MFPR Nihonbashi Honcho Building, Chuo-ku, Tokyo, JPN, 103-0023
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
69GF Score

Get the complete analysis for TSE:4263

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円818.00
Price
円974.33
GF Value